US Stock MarketDetailed Quotes
OM Outset Medical
- 0.838
- +0.077+10.15%
Close Nov 22 16:00 ET
- 0.814
- -0.023-2.78%
Post 18:55 ET
44.01MMarket Cap-305P/E (TTM)
0.899High0.742Low551.99KVolume0.760Open0.760Pre Close451.08KTurnover1.07%Turnover RatioLossP/E (Static)52.54MShares6.37052wk High0.92P/B43.19MFloat Cap0.43552wk Low--Dividend TTM51.57MShs Float66.960Historical High--Div YieldTTM20.55%Amplitude0.435Historical Low0.817Avg Price1Lot Size
Outset Medical Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 39.50%-20.57M | -18.31%-33.34M | -2.58%-45.91M | 9.85%-131.37M | 29.17%-24.44M | 0.91%-34M | 26.96%-28.18M | -16.75%-44.76M | -11.87%-145.73M | -5.60%-34.51M |
| Net income from continuing operations | 39.50%-27.94M | 21.78%-34.45M | 9.16%-39.94M | -6.04%-172.8M | 6.86%-38.6M | -13.24%-46.18M | -0.47%-44.05M | -19.19%-43.97M | -23.51%-162.96M | -0.51%-41.44M |
| Operating gains losses | -15.38%11K | ---- | ---- | ---- | ---- | --13K | ---- | ---- | --1.37M | ---- |
| Depreciation and amortization | -5.12%1.39M | -2.84%1.47M | 5.49%1.46M | 12.40%5.81M | 13.95%1.45M | 11.57%1.47M | 14.35%1.51M | 9.67%1.38M | 0.14%5.17M | -2.08%1.27M |
| Other non cash items | 30.94%1.02M | 27.28%989K | 28.65%952K | 115.72%3.39M | 273.04%1.09M | 84.16%779K | 75.40%777K | 79.61%740K | -6.04%1.57M | -39.21%293K |
| Change In working capital | -145.10%-414K | -333.42%-11.9M | -43.55%-15.46M | 96.34%-773K | 207.31%3.98M | 125.84%918K | 210.92%5.1M | -15.95%-10.77M | 17.42%-21.14M | -498.49%-3.71M |
| -Change in receivables | -110.26%-139K | 120.19%544K | 43.81%-3.5M | -103.27%-5.09M | 144.23%2.47M | -35.93%1.36M | -219.09%-2.7M | -379.14%-6.22M | 86.90%-2.51M | 11.34%-5.59M |
| -Change in inventory | 106.42%225K | -292.32%-6.23M | -342.99%-6.98M | 111.18%1.65M | -132.41%-960K | -47.29%-3.51M | 129.13%3.24M | 168.67%2.87M | 33.17%-14.73M | 171.95%2.96M |
| -Change in prepaid assets | 186.24%652K | 154.55%1.6M | -170.30%-400K | 160.82%739K | 115.39%299K | -214.89%-756K | 1,035.82%627K | 315.33%569K | -165.32%-1.22M | -270.14%-1.94M |
| -Change in payables and accrued expense | -108.41%-350K | -409.86%-7.64M | 32.66%-5.4M | 107.21%267K | 416.25%1.65M | 213.80%4.16M | -33.06%2.46M | -98.15%-8.01M | -131.60%-3.7M | -96.50%320K |
| -Change in other current liabilities | -26.40%-407K | -18.35%-387K | -21.09%-379K | -17.13%-1.35M | -25.82%-385K | -8.78%-322K | -18.05%-327K | -15.50%-313K | -30.39%-1.15M | -15.47%-306K |
| -Change in other working capital | -2,368.75%-395K | -88.09%213K | 251.03%1.2M | 39.52%3.02M | 6.50%901K | -260.00%-16K | 92.37%1.79M | -9.07%341K | -24.99%2.16M | -36.44%846K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 39.50%-20.57M | -18.31%-33.34M | -2.58%-45.91M | 9.85%-131.37M | 29.17%-24.44M | 0.91%-34M | 26.96%-28.18M | -16.75%-44.76M | -11.87%-145.73M | -5.60%-34.51M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -46.74%15.88M | 43.41%38.94M | -2,333.48%-59.03M | 225.24%83.03M | 145.27%23.43M | 47.85%29.81M | 2,163.30%27.15M | 107.92%2.64M | 53.48%-66.3M | -215.19%-51.75M |
| Net PPE purchase and sale | 49.49%-395K | 84.91%-120K | 56.30%-354K | 58.68%-3.44M | 50.07%-1.05M | 71.47%-782K | 60.19%-795K | 45.20%-810K | -167.86%-8.33M | -147.83%-2.11M |
| Net investment purchase and sale | -46.81%16.27M | 39.76%39.06M | -1,799.30%-58.68M | 249.16%86.47M | 149.31%24.48M | 33.57%30.59M | 4,003.96%27.95M | 110.82%3.45M | 58.41%-57.97M | -218.87%-49.64M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -46.74%15.88M | 43.41%38.94M | -2,333.48%-59.03M | 225.24%83.03M | 145.27%23.43M | 47.85%29.81M | 2,163.30%27.15M | 107.92%2.64M | 53.48%-66.3M | -215.19%-51.75M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -97.05%121K | -92.62%77K | 1,200.17%68.61M | -40.12%43.65M | -49.35%33.23M | 61.98%4.1M | 0.10%1.04M | 41.74%5.28M | -54.48%72.9M | 6,923.55%65.6M |
| Net issuance payments of debt | --0 | --0 | --66.52M | -48.77%33.23M | --33.23M | --0 | --0 | --0 | --64.86M | ---- |
| Net common stock issuance | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- |
| Proceeds from stock option exercised by employees | -97.05%121K | -92.62%77K | -60.47%2.09M | 29.66%10.43M | -99.34%4K | 53.79%4.1M | 0.10%1.04M | 41.74%5.28M | -27.30%8.04M | -34.80%609K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -97.05%121K | -92.62%77K | 1,200.17%68.61M | -40.12%43.65M | -49.35%33.23M | 61.98%4.1M | 0.10%1.04M | 41.74%5.28M | -54.48%72.9M | 6,923.55%65.6M |
| Net cash flow | ||||||||||
| Beginning cash position | 3.70%41.19M | -10.56%35.51M | -6.13%71.84M | -64.51%76.53M | -59.23%39.63M | -63.50%39.72M | -73.12%39.7M | -64.51%76.53M | -34.31%215.66M | -63.16%97.19M |
| Current changes in cash | -4,924.18%-4.57M | 28,315.00%5.68M | 1.37%-36.33M | 96.63%-4.7M | 255.95%32.21M | 99.22%-91K | 100.05%20K | 45.83%-36.84M | -23.53%-139.13M | 57.11%-20.66M |
| End cash Position | -7.60%36.62M | 3.70%41.19M | -10.56%35.51M | -6.13%71.84M | -6.13%71.84M | -59.23%39.63M | -63.50%39.72M | -73.12%39.7M | -64.51%76.53M | -64.51%76.53M |
| Free cash flow | 39.73%-20.96M | -15.48%-33.46M | -1.54%-46.27M | 12.49%-134.81M | 30.37%-25.5M | 6.13%-34.78M | 28.59%-28.97M | -14.45%-45.57M | -15.51%-154.05M | -9.21%-36.62M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
